Sheehan Disability Scale (SDS)
Also known as: SDS, Sheehan Disability Scale
The Sheehan Disability Scale is a brief three-item self-report measure designed by David V. Sheehan to assess functional impairment across work/school, social life, and family life domains in psychiatric and medical disorders. First described in Sheehan's 1983 book 'The Anxiety Disease' and validated in multiple studies since, the SDS quantifies the degree to which a patient's illness interferes with major life domains. It is widely used in psychiatric research and clinical practice to assess the functional impact of depression, anxiety, ADHD, and other conditions, complementing symptom severity measures by capturing real-world impairment.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Recommended for: assessing baseline functional impairment at treatment intake; monitoring treatment response in terms of real-world functioning (complementing symptom measures); evaluating disability claims or fitness-for-duty assessments; research assessing functional outcomes of psychiatric treatment; primary care screening for depression or anxiety with functional impact consideration. Particularly useful when distinguishing symptomatic improvement from functional recovery, and vice versa.
Strengths & limitations
- Exceptional brevity—three items, 1–2 minutes, practical for busy clinical settings and repeated administration without burden
- Directly addresses functional impairment—focus on work, social, and family domains captures real-world consequences of illness, not just symptom severity
- Widely validated across disorders—applicable to depression, anxiety, ADHD, bipolar disorder, psychosis, and medical conditions; robust psychometrics across populations
- Free public domain—no licensing restrictions; freely available in multiple languages
- Sensitive to treatment response—demonstrates good responsiveness to medication and psychotherapy, with meaningful functional improvements often paralleling symptom reduction
- Complements symptom measures—used alongside PHQ-9, GAD-7, or depression ratings; functional and symptom improvement together signal recovery
- Does not assess symptom severity—SDS measures functional impact only; cannot replace symptom measures; use alongside PHQ-9 or similar
- Limited to three life domains—work/school, social, family; does not assess other functions (self-care, cognitive, physical)
- Subjective judgment of impairment—patients may rate impairment differently based on expectations, insight, or effort; objective work or school records may differ
- Vulnerable to social desirability bias—patients may minimize impairment to appear more functional or maximize it to gain services
- Does not distinguish cause of impairment—a low SDS score could reflect mild symptoms, high resilience, or avoidance of activities; context is needed
- No subscale scores—three items cannot be subdivided; only total score interpretation
Frequently asked
What's the difference between symptom improvement and functional improvement?
Symptom improvement (e.g., PHQ-9 score reduction) indicates depressive symptoms are diminishing. Functional improvement (e.g., SDS score reduction) indicates the patient is resuming work, socializing, or family responsibilities. Both are important; some patients improve symptomatically but remain functionally impaired (lack motivation despite fewer symptoms), or vice versa.
How do I interpret a patient with low SDS despite significant depression symptoms?
Low SDS despite high symptom severity might reflect: preserved functioning despite symptoms (good resilience/support), avoidance of activities (so minimal impairment is rated, yet avoidance itself is a problem), or minimization due to stigma/social desirability bias. Interview the patient to clarify: 'Are you avoiding work/socializing, or are you doing these but struggling?' This context shapes treatment goals.
Can I use SDS to track treatment response over weeks and months?
Yes. SDS is sensitive to treatment response and practical for repeated administration every 2–4 weeks during acute treatment or monthly during maintenance. A meaningful reduction (≥3–5 points) over 8 weeks indicates functional improvement. Pairing SDS with symptom measures (PHQ-9) gives a fuller picture of recovery.
Is SDS appropriate for medical illness without psychiatric disorder?
Yes. While developed for psychiatric conditions, SDS validly measures functional impairment from medical illness. A cancer patient, diabetic, or stroke survivor can rate work and social impairment from medical symptoms. Use SDS to quantify functional burden and guide rehabilitation or medical management priority.
Sources
- Sheehan, D. V. (1983). The Anxiety Disease. New York: Scribner. ISBN: 9780684183078
- Leon, A. C., Olfson, M., & Portera, L. (1997). Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. International Journal of Psychiatry in Medicine, 27(2), 93–105. DOI: 10.2190/T8EM-C8YH-373N-1UWD ↗
- Arbuckle, R., Freston, M., & Witt, R. (2009). A systematic literature review of the psychometric properties and interpretation of the Sheehan Disability Scale. Current Medical Research and Opinion, 25(10), 2517–2526. link ↗
How to cite this page
ScholarGate. (2026, June 3). Sheehan Disability Scale (SDS). ScholarGate. https://scholargate.app/en/clinical-psychology/sheehan-disability-scale
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Clinical Global Impressions ScaleClinical Psychology↔ compare
- Patient Global Impression of ChangeClinical Psychology↔ compare
- Patient Health Questionnaire-9Clinical Psychology↔ compare
- Quick Inventory of Depressive SymptomatologyClinical Psychology↔ compare